Eduard Baco
- Senior consultant in urology; MD, PhD
Publications 2024
Urinary stone assessment in a single-phase may replace the unenhanced and multiphase computed tomography protocol in painless visible haematuria
Scand J Urol, 59, 147-155
DOI 10.2340/sju.v59.40679, PubMed 39268780
Computed tomography for visible haematuria - a single nephrographic phase is sufficient for detecting renal cell carcinoma
Scand J Urol, 59, 10-18
DOI 10.2340/sju.v59.18467, PubMed 38226799
Non-infectious adverse events of transperineal prostate biopsies performed under local anaesthesia
BJU Int, 134 (2), 300-306
DOI 10.1111/bju.16383, PubMed 38679416
Publications 2023
Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement
Eur Urol, 84 (6), 547-560
DOI 10.1016/j.eururo.2023.06.013, PubMed 37419773
Tissue distribution of ethanol after intraprostatic injection using a porous needle
Front Oncol, 12, 1063781
DOI 10.3389/fonc.2022.1063781, PubMed 36686794
Is a Single Nephrographic Phase Computed Tomography Sufficient for Detecting Urothelial Carcinoma in Patients with Visible Haematuria? A Prospective Paired Noninferiority Comparison
Eur Urol Open Sci, 55, 1-10
DOI 10.1016/j.euros.2023.06.005, PubMed 37693732
Re: Peter Ka-Fung Chiu, Veeru Kasivisvanathan, Giorgio Gandaglia, European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Moving the Needle: Antibiotic Prophylaxis Is No Longer Required in the Era of Transperineal Prostate Biopsy. Eur Urol. 2023;84:154-55
Eur Urol, 85 (4), e118-e119
DOI 10.1016/j.eururo.2023.06.024, PubMed 37482513
Publications 2022
Editorial Comment
J Urol, 207 (1), 33
DOI 10.1097/JU.0000000000002251.01, PubMed 34879759
Infection Rate after Transperineal Prostate Biopsy with and without Prophylactic Antibiotics: Results from a Systematic Review and Meta-Analysis of Comparative Studies EDITORIAL COMMENTS
J. Urol., 207 (1), 33
Predictive Performance of Prospectively Applied ISUP and Fuhrman Grade in Nonmetastatic Renal Cell Carcinoma
Anticancer Res, 42 (6), 2967-2975
DOI 10.21873/anticanres.15780, PubMed 35641263
Evaluation of systematic prostate biopsies when performing transperineal MRI/TRUS fusion biopsy with needle tracking-what is the additional value?
Int Urol Nephrol, 54 (10), 2477-2483
DOI 10.1007/s11255-022-03309-y, PubMed 35877030
Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial
Lancet Infect Dis, 22 (10), 1465-1471
DOI 10.1016/S1473-3099(22)00373-5, PubMed 35839791
Antibiotic prophylaxis for transperineal prostate biopsy? An unanswered question - Authors' reply
Lancet Infect Dis, 22 (12), 1663
DOI 10.1016/S1473-3099(22)00736-8, PubMed 36356607
Validating the screening criteria for bone metastases in treatment-naïve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases
Eur Radiol, 32 (12), 8266-8275
DOI 10.1007/s00330-022-08945-7, PubMed 35939081
Publications 2021
Cancer Detection Rates in Targeted Transperineal MRI-TRUS Elastic Fusion-guided Prostate Biopsies Performed Under Local Anesthesia
Anticancer Res, 41 (9), 4395-4400
DOI 10.21873/anticanres.15244, PubMed 34475059
Center experience and other determinants of patient radiation exposure during prostatic artery embolization: a retrospective study in three Scandinavian centers
Eur Radiol, 32 (4), 2404-2413
DOI 10.1007/s00330-021-08351-5, PubMed 34786614
Publications 2020
"TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now
Prostate Cancer Prostatic Dis, 23 (1), 62-65
DOI 10.1038/s41391-020-0204-8, PubMed 31932659
Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia
Urol Oncol, 39 (7), 432.e1-432.e7
DOI 10.1016/j.urolonc.2020.11.009, PubMed 33257219
The prevalence and locations of bone metastases using whole-body MRI in treatment-naïve intermediate- and high-risk prostate cancer
Eur Radiol, 31 (5), 2747-2753
DOI 10.1007/s00330-020-07363-x, PubMed 33141299
Publications 2019
Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry
World J Urol, 38 (1), 17-26
DOI 10.1007/s00345-019-02837-0, PubMed 31183524
Examining the upper urinary tract in patients with hematuria-time to revise the CT urography protocol?
Eur Radiol, 30 (3), 1664-1670
DOI 10.1007/s00330-019-06521-0, PubMed 31748856
MRI in the Follow-up of Testicular Cancer: Less is More
Anticancer Res, 39 (6), 2963-2968
DOI 10.21873/anticanres.13427, PubMed 31177136
Publications 2018
Outcome after prostatic artery embolization in patients with symptomatic benign prostatic hyperplasia
Acta Radiol, 60 (9), 1175-1180
DOI 10.1177/0284185118813709, PubMed 30450921
Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients
Int J Urol, 25 (12), 990-997
DOI 10.1111/iju.13796, PubMed 30187529
A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient
World J Urol, 36 (4), 629-637
DOI 10.1007/s00345-018-2171-4, PubMed 29349572
Re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722-8
Eur Urol, 75 (4), e103
DOI 10.1016/j.eururo.2018.11.047, PubMed 30528223
Publications 2016
Reply to Yi Zhou, Weigang Yan, and Hanzhong Li's Letter to the Editor re: Eduard Baco, Erik Rud, Lars Magne Eri, et al. A Randomized Controlled Trial to Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016;69:149-56
Eur Urol, 70 (2), e55
DOI 10.1016/j.eururo.2016.01.031, PubMed 26852076
Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes
Urol Oncol, 35 (1), 35.e15-35.e19
DOI 10.1016/j.urolonc.2016.08.012, PubMed 27692834
Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40: Is Contrast-enhanced Magnetic Resonance Imaging Really Necessary When Searching for Prostate Cancer?
Eur Urol, 70 (5), e136
DOI 10.1016/j.eururo.2016.04.017, PubMed 27126376
Publications 2015
A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy
Eur Urol, 69 (1), 149-56
DOI 10.1016/j.eururo.2015.03.041, PubMed 25862143
Personalized 3D printed model of kidney and tumor anatomy: a useful tool for patient education
World J Urol, 34 (3), 337-45
DOI 10.1007/s00345-015-1632-2, PubMed 26162845
The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery
World J Urol, 34 (3), 347-52
DOI 10.1007/s00345-015-1634-0, PubMed 26149352
Prostate Cancer Volume Estimation by Combining Magnetic Resonance Imaging and Targeted Biopsy Proven Cancer Core Length: Correlation with Cancer Volume
J Urol, 194 (4), 957-65
DOI 10.1016/j.juro.2015.04.075, PubMed 25912496
Does preoperative magnetic resonance imaging reduce the rate of positive surgical margins at radical prostatectomy in a randomised clinical trial?
Eur Urol, 68 (3), 487-96
DOI 10.1016/j.eururo.2015.02.039, PubMed 25813692
Publications 2014
Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study
BJU Int, 114 (4), 532-40
DOI 10.1111/bju.12545, PubMed 24930692
Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer
Urol Oncol, 32 (8), 1300-7
DOI 10.1016/j.urolonc.2014.07.014, PubMed 25189687
Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer
J Urol, 193 (2), 466-72
DOI 10.1016/j.juro.2014.08.084, PubMed 25150643
Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients
Eur Urol, 67 (4), 787-94
DOI 10.1016/j.eururo.2014.08.077, PubMed 25240973
Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies
AJR Am J Roentgenol, 202 (3), W241-6
DOI 10.2214/AJR.12.10483, PubMed 24555620
Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone
BJU Int, 114 (6b), E32-E42
DOI 10.1111/bju.12637, PubMed 24447606
Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer
World J Urol, 33 (7), 1015-21
DOI 10.1007/s00345-014-1362-x, PubMed 25059766
Publications 2013
Treatment of organ localized prostate cancer by High Intensity Focus Ultrasound: 15 years of clinical experience
E-Mem. Acad. Natl. Chir., 12 (1), 64-67
DOI 10.14607/emem.2013.1.064
Publications 2012
MRI and ultrasound-guided prostate biopsy using soft image fusion
Anticancer Res, 32 (8), 3383-9
PubMed 22843919
Publications 2011
Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer
Int J Urol, 18 (9), 646-51
DOI 10.1111/j.1442-2042.2011.02815.x, PubMed 21771102
Publications 2010
A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results
Scand J Urol Nephrol, 44 (4), 223-7
DOI 10.3109/00365591003727551, PubMed 20350272